Susanne Schaffert

Board member at Novo Holdings as of 1 May 2023.

Susanne Schaffert was born in 1967 and is a German national. She has a strong scientific academic background and holds a PhD and a Diploma in Chemistry (MSc) from the Institute of Organic Chemistry, University Erlangen in Germany, and has completed the Executive Leadership Program and Executive Finance Leadership Program at Harvard Business School.

In 2019-2022, Susanne Schaffert was President at Novartis Oncology in Basel, Switzerland, and has had a number of significant roles within the Novartis Group, including European General Manager of Novartis Oncology, Global Head of Investor Relations, and Global Franchise Head Immunology and Transplantation, as well as Global Brand Director. She holds a proven record of broad leadership and P&L experience on regional and global level within biotech, pharmaceuticals, specialised care and oncology, and has had a number of Board positions within EFPIA, Novartis and JV GSK-Novartis Consumer Health.

Other Board Positions and Management Duties:

• Member of the Executive Education Board of St. Gallen Business School